Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations.

MLA

Bench, Anthony J., et al. “Molecular Diagnosis of the Myeloproliferative Neoplasms: UK Guidelines for the Detection of JAK2 V617F and Other Relevant Mutations.” British Journal of Haematology, vol. 160, no. 1, Jan. 2013, pp. 25–34. EBSCOhost, https://doi.org/10.1111/bjh.12075.

APA

Bench, A. J., White, H. E., Foroni, L., Godfrey, A. L., Gerrard, G., Akiki, S., Awan, A., Carter, I., Goday-Fernandez, A., Langabeer, S. E., Clench, T., Clark, J., Evans, P. A., Grimwade, D., Schuh, A., McMullin, M. F., Green, A. R., Harrison, C. N., & Cross, N. C. P. (2013). Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations. British Journal of Haematology, 160(1), 25–34. https://doi.org/10.1111/bjh.12075

Chicago

Bench, Anthony J, Helen E White, Letizia Foroni, Anna L Godfrey, Gareth Gerrard, Susanna Akiki, Abida Awan, et al. 2013. “Molecular Diagnosis of the Myeloproliferative Neoplasms: UK Guidelines for the Detection of JAK2 V617F and Other Relevant Mutations.” British Journal of Haematology 160 (1): 25–34. doi:10.1111/bjh.12075.